{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:00:07Z","timestamp":1760821207350,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004785","name":"NordForsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2021.01.028","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:20:15Z","timestamp":1611865215000},"page":"1583-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden \u2013 An interrupted time-series analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Signe","family":"S\u00f8rup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Laake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heta","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Gehrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Feiring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lill","family":"Trogstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Stabell","family":"Benn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.01.028_b0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing tomorrow's vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.028_b0010","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/S1473-3099(19)30742-X","article-title":"Vaccinology: time to change the paradigm?","volume":"20","author":"Benn","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.028_b0015","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.01.028_b0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.2014.470","article-title":"Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections","volume":"311","author":"Sorup","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2021.01.028_b0025","article-title":"Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands","volume":"358","author":"Tielemans","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.01.028_b0030","unstructured":"Benn CS, Sorup S, Aaby P. Rapid Response: Re: Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands. https:\/\/www.bmj.com\/content\/358\/bmj.j3862\/rr-0 [Accessed: 6\/8\/2020]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0035","doi-asserted-by":"crossref","unstructured":"Bardenheier BH, McNeil MM, Wodi AP, McNicholl J, DeStefano F. Risk of non-targeted infectious disease hospitalizations among U.S. children following inactivated and live vaccines, 2005\u20132014. Clin Infect Dis. 2017.","DOI":"10.1093\/cid\/cix442"},{"key":"10.1016\/j.vaccine.2021.01.028_b0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/21645515.2019.1663119","article-title":"Non-specific effects of MMR vaccines on infectious disease related hospitalizations during the second year of life in high-income countries: a systematic review and meta-analysis","volume":"16","author":"Sinzinger","year":"2020","journal-title":"Human Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2021.01.028_b0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ebiom.2016.07.016","article-title":"Revaccination with live attenuated vaccines confer additional beneficial nonspecific effects on overall survival: a review","volume":"10","author":"Benn","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2021.01.028_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/ciy433","article-title":"Revaccination with measles-mumps-rubella vaccine and infectious disease morbidity: a Danish register-based cohort study","volume":"68","author":"Sorup","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.028_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2750","article-title":"Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis","volume":"350","author":"Kontopantelis","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.01.028_b0060","unstructured":"Glismann S, Christiansen AH. MFR2-vaccination fremrykkes til 4 \u00e5rs alderen. In: Andersen PH, editor. EPI-NYT2008."},{"key":"10.1016\/j.vaccine.2021.01.028_b0065","unstructured":"Socialstyrelsen. Socialstyrelsens f\u00f6reskrifter om vaccination av barn; 2006."},{"key":"10.1016\/j.vaccine.2021.01.028_b0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2021.01.028_b0075","unstructured":"Socialdepartementet. Smittskyddslag (2004:168) http:\/\/www.riksdagen.se\/sv\/dokument-lagar\/dokument\/svensk-forfattningssamling\/smittskyddslag-2004168_sfs-2004-168 [Accessed: 22\/10\/2019]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0080","unstructured":"Hasvold T. 6. Denmark. In: Kringos DS, Boerma WGW, Hutchinson A, Saltman RB, editors. Building primary care in a changing Europe: case studies. Copenhagen (Denmark); 2015. p. 49\u201359."},{"key":"10.1016\/j.vaccine.2021.01.028_b0085","unstructured":"Patientavgifter och h\u00f6gkostnadsskydd. https:\/\/www.1177.se\/sa-fungerar-varden\/kostnader-och-ersattningar\/patientavgifter\/ [Accessed: 3\/8\/2020]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0090","first-page":"7497","article-title":"The childhood vaccination program. Background, status and future","volume":"156","author":"Plesner","year":"1994","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.vaccine.2021.01.028_b0095","unstructured":"Folkh\u00e4lsomyndigheten. Barnvaccinationsprogrammet i Sverige; 2018. https:\/\/www.folkhalsomyndigheten.se\/contentassets\/bd48e34a891845d9a0289b2124ad9cf2\/barnvaccinationsprogrammet-2018-19037.pdf."},{"key":"10.1016\/j.vaccine.2021.01.028_b0100","unstructured":"Smittskyddsinstitutet. Epidemiologisk \u00e5rsrapport; 2008. https:\/\/www.folkhalsomyndigheten.se\/contentassets\/80cf33459344489aac415cb5d28868c5\/epidemiologisk-arsrapport-2008.pdf."},{"key":"10.1016\/j.vaccine.2021.01.028_b0105","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2021.01.028_b0110","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ije\/dyy135","article-title":"The use of controls in interrupted time series studies of public health interventions","volume":"47","author":"Lopez Bernal","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2021.01.028_b0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2021.01.028_b0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2021.01.028_b0125","unstructured":"Statistics Denmark. https:\/\/www.statbank.dk\/FOLK2 [Accessed: 12\/11\/2019]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0130","unstructured":"Statistics Sweden. http:\/\/www.statistikdatabasen.scb.se\/pxweb\/en\/ssd\/START__BE__BE0101__BE0101A\/BefolkningNy\/?rxid=f5bf3beb [Accessed: 3\/12\/2019]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0135","unstructured":"Juul S, Frydenberg M, Hansen S. EpiBasic-Simple statistical tools for epidemiological analyses; 2019."},{"key":"10.1016\/j.vaccine.2021.01.028_b0140","unstructured":"UCLA: Statistical Consulting Group. POISSON REGRESSION | R DATA ANALYSIS EXAMPLES. https:\/\/stats.idre.ucla.edu\/r\/dae\/poisson-regression\/ [Accessed: 16\/6\/2020]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0304-4076(90)90014-K","article-title":"Regression-based tests for overdispersion in the poisson model","volume":"46","author":"Cameron","year":"1990","journal-title":"J Economet"},{"key":"10.1016\/j.vaccine.2021.01.028_b0150","article-title":"Creating effective interrupted time series graphs: review and recommendations","author":"Turner","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.vaccine.2021.01.028_b0155","unstructured":"Valentiner-Branth P, Glismann S, Knudsen LK, Simonsen J. Tilslutning til MFR-vaccination 2010. EPI-NYT2011."},{"key":"10.1016\/j.vaccine.2021.01.028_b0160","doi-asserted-by":"crossref","unstructured":"Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Molvadgaard M, Fons Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2012;17.","DOI":"10.2807\/ese.17.05.20073-en"},{"key":"10.1016\/j.vaccine.2021.01.028_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100474","article-title":"Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions","volume":"17","author":"Liu","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.vaccine.2021.01.028_b0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.12956","article-title":"The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden","volume":"286","author":"Naucler","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2021.01.028_b0175","unstructured":"Valentiner-Branth P, Andersen PH, Chrsistiansen AH, Vestergaard L, Glismann S, Christensen JJ, et al. Pneumokokvaccine i b\u00f8rnevaccinationsprogrammet. In: Andersen PH, editor. EPI-NYT2007."},{"key":"10.1016\/j.vaccine.2021.01.028_b0180","unstructured":"Folkh\u00e4lsomyndigheten. Tidigare vaccinationsprogram. https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/vaccinationsprogram\/tidigare-vaccinationsprogram\/ [Accessed: 25\/8\/2020]."},{"key":"10.1016\/j.vaccine.2021.01.028_b0185","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.028_b0190","doi-asserted-by":"crossref","first-page":"ofv204","DOI":"10.1093\/ofid\/ofv204","article-title":"Oral polio vaccination and hospital admissions with non-polio infections in Denmark: nationwide retrospective cohort study","volume":"3","author":"Sorup","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.028_b0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14760584.2018.1471987","article-title":"How to evaluate potential non-specific effects of vaccines: the quest for randomized trials or time for triangulation?","volume":"17","author":"Benn","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.01.028_b0200","doi-asserted-by":"crossref","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.01.028_b0205","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.vaccine.2018.02.104","article-title":"No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: a randomized controlled trial","volume":"36","author":"Schoeps","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.028_b0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vaccine.2016.11.049","article-title":"A general measles vaccination campaign in urban Guinea-Bissau: comparing child mortality among participants and non-participants","volume":"35","author":"Byberg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.028_b0215","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/INF.0000000000000896","article-title":"Reduced all-cause child mortality after general measles vaccination campaign in rural Guinea-Bissau","volume":"34","author":"Fisker","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.01.028_b0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fped.2020.00020","article-title":"Measles vaccination in presence of measles antibody may enhance child survival","volume":"8","author":"Benn","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2021.01.028_b0225","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cid\/ciu354","article-title":"Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival","volume":"59","author":"Aaby","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2100044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:16Z","timestamp":1759403416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2100044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X2100044X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden \u2013 An interrupted time-series analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}